• Disclaimer

    Dec 19, 2025, 11:50

  • Editorial Board

    Dec 16, 2025, 09:49

  • HTA300 Simulating PICOs to Predict Evidence Requirement Implications of the EU Joint Clinical Assessment: Learnings From 24 Case Studies

    Dec 1, 2025, 00:00

  • HSD100 Rising Polypharmacy Trends and Associated Factors in Chinese Adults With Diabetes: A Population-Based Cohort Study

    Dec 1, 2025, 00:00

  • PCR219 Socioeconomic Burden of Pulmonary Arterial Hypertension on Patients and Caregivers in the Czech Republic

    Dec 1, 2025, 00:00

  • HPR218 Through a Glass Darkly: The What, How, and What Now for Global Net Price Transparency

    Dec 1, 2025, 00:00

  • EE369 Economic Consequences of Disease-Related Malnutrition in Poland and the Potential Cost Savings From Nutritional Interventions: A Two-Step Modeling Study

    Dec 1, 2025, 00:00

  • HSD93 Real-World Differences in Breast Cancer Management by Detection Method: A Czech National Analysis

    Dec 1, 2025, 00:00

  • EPH155 KRAS Alterations in Advanced Non-Small Cell Lung Cancer (NSCLC): Temporal Trends in Testing Patterns and Targeted Treatment Use Across Europe Between 2018 and 2024

    Dec 1, 2025, 00:00

  • EPH180 Pharosight: A Shiny-Based Interactive Platform With LLM-Enhanced Analyses and Predictive Modeling for Real-World Prescription Data

    Dec 1, 2025, 00:00

  • PCR167 Outcome Measures Relevant for Assessing Health-Related Quality of Life and Utility in Primary Lateral Sclerosis (PLS)

    Dec 1, 2025, 00:00

  • SA12 An Interactive Tool to Select Indirect Treatment Comparison Methods for Rapid Feasibility Assessment

    Dec 1, 2025, 00:00

  • EE284 Cost-per-Remission of Vedolizumab vs. Risankizumab for the Treatment of Moderate-to-Severely Active Crohn’s Disease in Italy, France, and Canada

    Dec 1, 2025, 00:00

  • HTA291 Rising EAP Rejection Rates and Their Impact on Drug Access in France

    Dec 1, 2025, 00:00

  • HTA72 Challenges in Predicting the Joint Clinical Assessment (JCA) Scope From a Stakeholder Perspective: A Case Study in Relapsed/Refractory Multiple Myeloma

    Dec 1, 2025, 00:00

  • EE152 Considerations for Modeling Caregiver Spillover Within Economic Evaluations for Neurological Disorders: Spinal Muscular Atrophy (SMA), Duchenne Muscular Dystrophy (DMD), and Multiple Sclerosis (MS)

    Dec 1, 2025, 00:00

  • HSD34 Digital Divide in Health Information Seeking: Rural and Urban Differences in the Use of Online Health Tools in the United States

    Dec 1, 2025, 00:00

  • PCR85 Evaluation and Validation of the Hypoparathyroidism Daily Diary of Symptom Experience (HPT-DD-SE) and the Hypoparathyroidism Life Impact Questionnaire (HPT-LIQ)

    Dec 1, 2025, 00:00

  • RWD122 Medical Resource Utilizations and Economic Burden of Chemotherapy-Induced Anemia in Chinese Population: A Multicenter Retrospective Study

    Dec 1, 2025, 00:00

  • P32 The Healthcare Improvement Scotland Think Frailty Tool: A Preliminary Psychometric Evaluation

    Dec 1, 2025, 00:00

  • HTA245 Navigating Joint Clinical Assessment in Europe: Strategic Roadmap and Recommendations for Health Technology Developers

    Dec 1, 2025, 00:00

  • EE104 Budget Impact of an Ambulatory Minimally Invasive Surgical Treatment in an Italian Public Hospital

    Dec 1, 2025, 00:00

  • CO95 Efficacy and Safety of Once-Weekly and Once-Daily Basal Insulins in Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis of Clinical Trials

    Dec 1, 2025, 00:00

  • EPH124 Heatstroke Is Associated With an Increased Risk of Chronic Headache: A Retrospective Cohort Study in Germany

    Dec 1, 2025, 00:00

  • EE144 Comparison of the Environmental Impact of Subcutaneous vs. Oral Therapies

    Dec 1, 2025, 00:00

  • MSR45 Bayesian Parametric Mixture Cure Survival Models With Delayed Treatment Effects and Application to Targeted Therapies in Advanced Ovarian Cancer

    Dec 1, 2025, 00:00

  • HTA16 A Systematic Literature Review of the Mitigation Strategies to Overcome the Risk for Confounding of Overall Survival in Trials With Crossover/Treatment Switching Evaluated in Health Technology Assessments of Treatments for Select Tumo ...

    Dec 1, 2025, 00:00

  • PCR75 Enhancing Understanding of Quality of Life in Multiple Sclerosis Through Social Listening: Complementing Traditional HRQoL Measures

    Dec 1, 2025, 00:00

  • PCR14 Advancing Patient-Centered Value Assessment in Inherited Retinal Diseases: Leveraging EQ-5D-5L Vision Bolt-ons to Support IRD-Specific PROMs

    Dec 1, 2025, 00:00

  • HPR200 The Evolving Horizon of Oncology: Predicting the Impact of the EU HTA Regulation for 2026-2029

    Dec 1, 2025, 00:00

  • MSR36 Artificial Intelligence in Systematic Reviews: An Investigation Into the Impact of Eligible Studies Being Excluded by Artificial Intelligence

    Dec 1, 2025, 00:00

  • HTA190 HTA Submission Trends for EMA-Approved Oncology NASs Prior to the EU HTA Regulation 2018-2023

    Dec 1, 2025, 00:00

  • MT34 Patient Acceptance of Health Information Technologies: Comparative Insights From Wearables, TelE-Medicine, and mHealth

    Dec 1, 2025, 00:00

  • PCR72 Enhancing Equity in Cancer Clinical Trials: A Synthesis of Patient-Reported Barriers and Sustainable Solutions

    Dec 1, 2025, 00:00

  • EE288 Costs Associated With Kidney Transplant in Portugal

    Dec 1, 2025, 00:00

  • PCR162 Multinational Qualitative Testing of the Experimental EuroQol Toddler and Infant Populations (EQ-TIPS) Instrument

    Dec 1, 2025, 00:00

  • HTA89 CONITEC in Action: A Trend Analysis of CONITEC’s Evaluation Outcomes From 2020 to Present Day

    Dec 1, 2025, 00:00

  • EE213 Cost-Effectiveness Analysis of Oral Semaglutide As a Third-Line Treatment for Patients With Type 2 Diabetes Mellitus

    Dec 1, 2025, 00:00

  • EE81 Budget Impact Analysis of Dimethyl Fumarate for the Treatment of Relapsing/Remitting Multiple Sclerosis in Iraq

    Dec 1, 2025, 00:00

  • EPH55 COVID-19 mRNA-1273 Vaccination in the UK: A Comparative Modeling Study of Alternative Eligibility Criteria

    Dec 1, 2025, 00:00

  • EE646 Regulatory Approval and Economic Evaluation of Tumor-Agnostic Therapies: A Comparative Study of Larotrectinib and Entrectinib

    Dec 1, 2025, 00:00

  • HTA159 Funding the Fight Against Antimicrobial Resistan Learnings From the UK and Sweden’s Pilot Incentive Programs

    Dec 1, 2025, 00:00

  • RWD48 DARWIN EU® Characterizing Clinically Recognized Hypertrophic Cardiomyopathy in Six European Countries: A Descriptive Analysis Using Real-World Data

    Dec 1, 2025, 00:00

  • HTA307 Surrogate Outcome Validation Within the New EU HTA Guidance Framework: Practical Considerations From an Industry Perspective Based on Experience From HTA Germany

    Dec 1, 2025, 00:00

  • HSD80 Organizational Support in Adopting New Treatments for Generalized Myasthenia Gravis

    Dec 1, 2025, 00:00

  • RWD144 Real-World Healthcare Resource Utilization and Related Costs Associated With Schizophrenia in the Brazilian Private Market

    Dec 1, 2025, 00:00

  • EE579 Micro-Costing Analysis of the Economic Burden of Metabolic Dysfunction-Associated Steatohepatitis and Its Comorbidities in Saudi Arabia

    Dec 1, 2025, 00:00

  • HPR232 Use of High-Cost Medicines in Secondary Care Settings in the English National Health Service

    Dec 1, 2025, 00:00

  • HPR62 Do Patient-Reported Outcomes Influence Drug Prices? Evidence From the Italian Pricing and Reimbursement System

    Dec 1, 2025, 00:00

  • SA35 Disease-Free Survival as a Surrogate Endpoint for Overall Survival in Patients With Adjuvant Treatments for Completely Resected Stage I-III Non-Small Cell Lung Cancer: A Systematic Literature Review and Meta-Analyses

    Dec 1, 2025, 00:00

  • EE99 Budget Impact Analysis of Tenecteplase vs. Alteplase for Adults With Acute Ischemic Stroke (AIS) in Greece

    Dec 1, 2025, 00:00

  • HTA151 From French Early Access to Regular Reimbursement: How Do Prices Shift Post-HTA?

    Dec 1, 2025, 00:00

  • PCR50 Comparison of Clinical Outcome Assessment in Randomized Controlled Trials and in Observational Studies for Amyotrophic Lateral Sclerosis: A Scoping Review

    Dec 1, 2025, 00:00

  • EE477 Forecasting Uptake of Novel Drugs Used for Atopic Dermatitis in Sweden Based on Historic RWE

    Dec 1, 2025, 00:00

  • PCR30 Beyond the Conversation: A Narrative Review of Cost-Informed Shared Decision Making and Its Impact on Medication Adherence in Chronic Conditions

    Dec 1, 2025, 00:00

  • EE740 Uncovering the Cost Landscape of Congenital Heart Disease (CHD) With a Life Course Perspective: A Systematic Review of Healthcare Utilization by Lesion Type and Age

    Dec 1, 2025, 00:00

  • EE186 Cost per Responder of TAR-200 vs. Other FDA-Approved Novel and Generic Treatments Among Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer With Carcinoma in Situ in the United States

    Dec 1, 2025, 00:00

  • HPR227 Understanding Reimbursement and Access Policies for Immunoglobulins and Other Plasma-Derived Medicinal Products Across Europe

    Dec 1, 2025, 00:00

  • EPH100 Examining The Relationship Between Diabetes Mellitus and Eating Disorders

    Dec 1, 2025, 00:00

  • EE400 Economic Impact of Lenalidomide-Refractory Multiple Myeloma in Finland: Insights From Real-World Data

    Dec 1, 2025, 00:00

  • HTA182 How Will Patient Registry Data Play a Role in Joint Clinical Assessment (JCA) for Rare Diseases Learnings From National Health Technology Assessments (HTAs)?

    Dec 1, 2025, 00:00

  • EE90 Budget Impact Analysis of Introducing the Elecsys® PRO-C3 Assay as Part of the ADAPT Algorithm for Assessing the Severity of Hepatic Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the UK

    Dec 1, 2025, 00:00

  • RWD20 Assessing the Clinical and Economic Burden of Surgical Bleeding in Switzerland

    Dec 1, 2025, 00:00

  • HTA305 Supplementing Single-Arm Trial Data in NICE Submissions: Are Synthetic Approaches Leading the Charge?

    Dec 1, 2025, 00:00

  • EE532 Impact of Higher-Valent Pediatric Pneumococcal Vaccines on Antimicrobial Resistant Infections and Antibiotic Prescriptions in Greece

    Dec 1, 2025, 00:00

  • EE404 Economic Value of Dupilumab in Preventing and Treating Comorbid Asthma in Pediatric Patients With Atopic Dermatitis: A Cost-Offset Model From the Italian Payer Perspective

    Dec 1, 2025, 00:00

  • HTA198 Importance of Decisional Context in the Health Technology Assessment (HTA) of Ultra-Orphan Drugs

    Dec 1, 2025, 00:00

  • HSD54 Guideline-Driven Off-Label Oncology Use: The Role of Clinical Evidence and Reimbursement Dynamics in the EU4+UK, Switzerland, and Canada

    Dec 1, 2025, 00:00

  • HPR92 Factors Impacting GKV Rebates for Orphan Drugs (OD) in Germany: A Decision Analysis Using the CRA RADAR Database

    Dec 1, 2025, 00:00

  • HPR33 Barriers and Facilitators Influencing the Development of Complex Generics: An Exploratory Study

    Dec 1, 2025, 00:00

  • PCR63 Development of Two Versions of a Patient-Preference Questionnaire for Evaluating Potential HIV Cure-Related and Other HIV Interventions

    Dec 1, 2025, 00:00

  • CO169 Network Meta-Analysis NMA of Clinical Effectiveness of Second-Line (2L+) Treatments in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

    Dec 1, 2025, 00:00

  • EE295 Cost-Utility Analysis (CUA) of Sepiapterin for Treatment of Phenylketonuria (PKU)

    Dec 1, 2025, 00:00

  • HTA299 Simulated Treatment Comparisons in NICE Technology Appraisals: Frequency Trends and Implications

    Dec 1, 2025, 00:00

  • PCR35 Can We Quantify the Financial Impact of Patient-Reported Outcomes on the Value of Oncology Products?

    Dec 1, 2025, 00:00

  • HPR5 A Comparative Analysis of Similarities and Differences of RWE Standards Across Regulatory and Health Technology Assessment Bodies

    Dec 1, 2025, 00:00

  • EE181 Cost of Illness Study: Cushing's Syndrome in the Kingdom of Saudi Arabia

    Dec 1, 2025, 00:00

  • EPH129 Hospitalization and Healthcare Consumption Burden of Respiratory Syncytial Virus (RSV) in Adults Over 50 years in France (RESVYR Study)

    Dec 1, 2025, 00:00

  • RWD171 Scaling Responsible Healthcare Data Access With AI-Driven Sensitive Patient Variable Detection

    Dec 1, 2025, 00:00

  • EE327 Development of a Discrete Event Simulation Model to Explore the Potential Cost-Effectiveness for Cancer Early Detection Testing in Female BRCA Carriers

    Dec 1, 2025, 00:00

  • HTA335 The Use of Real-World Evidence in Health Technology Assessment and the Application of the NICE RWE Framework: A Review of NICE Technology Appraisals

    Dec 1, 2025, 00:00

  • HTA129 Evaluating an Augmented Reality Software for Mechanical Thrombectomy Using the Lean Assessment Process Methodology: Identifying Clinical Needs, Stakeholder Acceptance, and Adoption Barriers in the NHS

    Dec 1, 2025, 00:00

  • HPR161 Physicians’ Knowledge, Attitude, and Practice Regarding Medical Liability: A Study in Saudi Arabia

    Dec 1, 2025, 00:00

  • HPR27 Annual Change in Türkiye’s Reimbursement List: A Comparative Descriptive Analysis of the 2023 and 2024 SUT Annex 4-A Lists

    Dec 1, 2025, 00:00

  • EPH77 Epidemiological Trends in HPV-Related Cancers and Diseases in the United Kingdom

    Dec 1, 2025, 00:00

  • SA102 Viable Rate of Return for Social Impact Bonds Supporting Research and Development of Gene Therapies for Rare Conditions

    Dec 1, 2025, 00:00

  • EE519 Hereditary Transthyretin Amyloidosis (ATTRv) Below the Age of 70 Healthcare Resource Utilization and Mortality

    Dec 1, 2025, 00:00

  • EE482 Half-Cycle Correction: It’s Time to Let It Go

    Dec 1, 2025, 00:00

  • HTA232 Methodological Insights From Recent PBAC Recommendations to Support Biosimilar Reimbursement in Australia

    Dec 1, 2025, 00:00

  • MSR38 Assessing Accuracy of Unsupervised Large Language Model Tools for Identifying Key Criteria Supporting Abstract Screening

    Dec 1, 2025, 00:00

  • CO79 Early Change in Proteinuria as a Surrogate Endpoint in Studies of IgA Nephropathy: An Updated Patient-Level Meta-Analysis and Discussion of Appropriate Methodology

    Dec 1, 2025, 00:00

  • MSR42 Automating PICOs Criteria Assessment in Systematic Reviews With LLMs: Insights From Two Case Studies

    Dec 1, 2025, 00:00

  • EE729 The Working Dead? Why Longer Lives Can Seem Less Productive

    Dec 1, 2025, 00:00

  • MSR34 Artificial Intelligence Detection of National Clinical Practice Gaps in Hormone-Sensitive Prostate Cancer (HSPC) in Brazil: A Patient-Centered Framework

    Dec 1, 2025, 00:00

  • HPR64 Drivers and Barriers of Biosimilar Uptake in APAC

    Dec 1, 2025, 00:00

  • EE486 Healthcare Resource Utilization and Costs Among Various Disease States in Adults With Hepatitis Delta Virus in Inpatient and Outpatient Settings in the United States

    Dec 1, 2025, 00:00

  • HTA163 Germany: Still a Benchmark for ATMP Access and Pricing: A Pricing Analysis of Germany's ATMP Landscape Compared to Other European Countries

    Dec 1, 2025, 00:00

  • EE682 Targeted Literature Review Informing Economic Model Structures in Atherosclerotic Cardiovascular Disease

    Dec 1, 2025, 00:00

  • HSD5 AI-Enabled Extraction of eGFR and BRAF Testing Patterns in Advanced NSCLC: IMPACT-NSCLC, a Multicenter Real-World Study (2019-2024)

    Dec 1, 2025, 00:00

  • RWD126 MIRROR KEYNOTE: Generating Real-World External Control Arms in Non-Small Cell Lung Cancer Using a Curated Database

    Dec 1, 2025, 00:00

  • HPR165 Price-Volume Regulation in Fran Alignment Between Negotiated Thresholds With the French Economic Committee for Health Products (CEPS) and Real-World Observations

    Dec 1, 2025, 00:00

  • EPH201 Quantification of the HPV-Attributable Cancer Mortality in Gree Years of Life Lost and Productivity Costs

    Dec 1, 2025, 00:00

  • CO45 Clinical Efficacy and Safety of Targeted Therapies for HER2 Mutant Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • PT4 Developing a Novel Model Structure for Evaluating Treatment Sequences in Oncology Pathways: A Pilot in Non-Small Cell Lung Cancer

    Dec 1, 2025, 00:00

  • CO1 A Balancing Act: Low-Dose Atropine Significantly Slows Pediatric Myopia Progression Without a Clinically Meaningful Risk of Rebound (Accelerated Myopia Progression Following Treatment Cessation)

    Dec 1, 2025, 00:00

  • HSD79 Optimizing Workforce Efficiency and Reducing Waiting Lists Through Remote Monitoring in Obstructive Sleep Apnea (OSA) Care in NHS

    Dec 1, 2025, 00:00

  • RWD17 An Algorithm to Identify Immunocompromised Patients in French Claims Data for Rapid Preventive or Therapeutic Interventions

    Dec 1, 2025, 00:00

  • EE418 Estimating Costs Avoided by Preventing Recurrences With a BRCA Testing Strategy in High-Risk HER2-Negative Adjuvant Breast Cancer Patients in Spain

    Dec 1, 2025, 00:00

  • EE248 Cost-Effectiveness of Epigenetic Drugs in Oncology: A Systematic Review of Economic Evaluations

    Dec 1, 2025, 00:00

  • HPR216 The Value of Rare Pediatric Disease Designation Program for Decision Making by Drug Developers

    Dec 1, 2025, 00:00

  • RWD164 Real-World Treatment Patterns and Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Previously Treated With First-Line (1L) Platinum-Based Chemotherapy (PBC)

    Dec 1, 2025, 00:00

  • HTA92 Cost-Effectiveness Analysis of Aztreonam Avibactam (ATMAVI) ± Metronidazole (MTZ) for the Treatment of Complicated Intra-Abdominal Infections (cIAIs) and Ventilator-Associated Hospital-Acquired Pneumonia (HAP/VAP) Caused by Suspected ...

    Dec 1, 2025, 00:00

  • PCR211 Review of Patient Decision Aids for Psoriasis

    Dec 1, 2025, 00:00

  • CO199 Real Option Value of Sotatercept in Pulmonary Arterial Hypertension: A Health Economic Perspective on Future Treatment Opportunities

    Dec 1, 2025, 00:00

  • HSD28 COVID-19's Effects on Mental Health Services: The Effectiveness of Telepsychiatry and Challenges in Substance Use Disorders in the United States

    Dec 1, 2025, 00:00

  • PCR98 Factors Influencing Intent to Vaccinate Against Respiratory Syncytial Virus (RSV) Among Older Adults in Australia, Hong Kong, Japan, New Zealand, South Korea, Singapore, and Taiwan

    Dec 1, 2025, 00:00

  • CO172 Nutritional Profile and Cost Evaluation of Elderly Patients in Home Care Within the Brazilian Private Health Sector: A Retrospective Study

    Dec 1, 2025, 00:00

  • EE64 Assessing the Value of Purewick™ System for the Management of Female Patients With Urinary Incontinence in the Nonacute Setting: Cost-Effectiveness Analysis

    Dec 1, 2025, 00:00

  • EE537 Impact of Mucus Plugs on the Health Economic Burden in Chronic Obstructive Pulmonary Disease (COPD) Patients

    Dec 1, 2025, 00:00

  • EE636 Real-World Evidence on Healthcare Resource Utilization (HCRU) and Economic Burden of Patients With COPD Treated With Dual or Triple Therapy: Stratified Analysis by Blood Eosinophil Count and Exacerbation Phenotype in the BREATHE-IN St ...

    Dec 1, 2025, 00:00

  • EE343 Dominance in Economic Evaluation as a Leverage in Pharmaceutical Price Negotiation

    Dec 1, 2025, 00:00

  • SA11 An AI-Enhanced Targeted Literature Review Workflow to Support Inclusive Research Practices and Population Science Research: A Human-in-the-Loop Approach

    Dec 1, 2025, 00:00

  • PCR216 Significant Burden of Chronic Obstructive Pulmonary Disease (COPD) on Health Status and Well-Being Persists Among Patients Experiencing One Severe or Two or More Moderate Exacerbations of COPD (ECOPD) and Their Caregivers (CGs)

    Dec 1, 2025, 00:00

  • CO234 The Association of Glucagon-Like Peptide-1 Receptor Agonists With Hepatopancreatobiliary Diseases in Individuals With Type 2 Diabetes Mellitus

    Dec 1, 2025, 00:00

  • EE190 Cost Comparison of Alternative Delivery Routes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) in the English National Health Service (NHS)

    Dec 1, 2025, 00:00

  • PCR64 Development of Two Versions of a Patient-Reported Outcome Measure to Evaluate Participant Experience and Satisfaction During the Intervention and Analytical Treatment Interruption Periods of Cure-Related and Other HIV Trials

    Dec 1, 2025, 00:00

  • EE705 The Economic Impact of Time-to-Target-Temperature of Different Surface Cooling Technologies for Temperature Management in Critically Ill Patients: A Systematic Review, Analysis, and Model

    Dec 1, 2025, 00:00

  • HPR154 Patient Pathways to Accessing Unregistered Medicines in Low-Priority Launch Markets

    Dec 1, 2025, 00:00

  • EE114 Budget Impact of the VELYS™ Robotic-Assisted Solution Compared to Manual Procedure in Patients Undergoing Primary Total Knee Arthroplasty in Spain

    Dec 1, 2025, 00:00

  • EE113 Budget Impact of the VELYS™ Robotic-Assisted Solution Compared to Manual Procedure in Patients Undergoing Primary Total Knee Arthroplasty in Italy

    Dec 1, 2025, 00:00

  • PCR77 Equivalence of Measurement Properties of the Dermatology Life Quality Index (DLQI) Across 13 European Countries

    Dec 1, 2025, 00:00

  • HTA63 Building the Bridge to Access: Leveraging RWE From Early Access Schemes to Reimbursement in Gene and Cell Therapies

    Dec 1, 2025, 00:00

  • HPR72 EU HTA, Joint Clinical Assessment, and JCA Report: What Is the Possible Impact on Price Negotiation for Orphan Drugs in Germany?

    Dec 1, 2025, 00:00

  • MSR145 Measuring the Elephant in the Room: Quantifying Legal Barriers to AI Processing of Full-Text in Systematic Reviews

    Dec 1, 2025, 00:00

  • MSR60 Comparison EQ-5D-Y-3L Responses Between Child Self-Reports and Caregiver Proxy Reports

    Dec 1, 2025, 00:00

  • HTA64 Canadian HTA Decisions (2020-2023): Comparing CDA-AMC and INESSS Recommendations on Drug Reimbursement

    Dec 1, 2025, 00:00

  • EE267 Cost-Effectiveness of Peripheral Neuropathy Screening in Malaysian Adults With Thalassemia: An Integrated Modeling Approach

    Dec 1, 2025, 00:00

  • SA105 Where Is AI in Evidence Synthesis for NICE HTA Submissions?

    Dec 1, 2025, 00:00

  • MSR30 Applying G-methods to Account for Treatment Switching in Postmarketing Effectiveness Evaluation: A Case Study of GLP-1 Receptor Agonists for Diabetic Kidney Disease

    Dec 1, 2025, 00:00

  • EE378 Economic Evaluation of Contemporary First-Line (1L) Treatments for Locally Advanced or Metastatic Urothelial Carcinoma La/mUC in Fran A Sensitivity Analysis

    Dec 1, 2025, 00:00

  • HTA340 Transportability of Overall Survival in Multiple Myeloma From the US to Germany: A Benchmarking Study

    Dec 1, 2025, 00:00

  • PCR99 Framing Matters! Implications of Loss Aversion for Communicating Benefits to Patients in Preference Studies (and Beyond)

    Dec 1, 2025, 00:00

  • EE678 Systematic Review of Decision-Analytic Models Estimating the Economic Impact of Prescription Opioid Use and Associated Adverse Events

    Dec 1, 2025, 00:00

  • P37 Advancing Preference Elicitation Techniques for Rare Diseases and Limited Sample Populations

    Dec 1, 2025, 00:00

  • EE525 Impact of Anosmia Severity on Health Utility Values in Chronic Rhinosinusitis With Nasal Polyps: An Exploratory Analysis From the WAYPOINT Trial

    Dec 1, 2025, 00:00

  • MSR164 Patients With Lupus Across Germany: An AI/ML Driven Method to Maximize Patient Selection From Longitudinal Prescription Data (IQVIA LRx)

    Dec 1, 2025, 00:00

  • EE670 Spinal Muscular Atrophy Treatments in Fran What Are the Organizational Economic and Environmental Impacts of Oral and Intrathecal Administrations

    Dec 1, 2025, 00:00

  • HTA212 Is Protocolized Stopping Lifelong Therapy With Eculizumab With Disease Monitoring and Retreatment for Eligible Atypical Hemolytic Uremic Syndrome (aHUS) Patients Cost-Effective? An Economic Evaluation of the SETS aHUS Trial

    Dec 1, 2025, 00:00

  • EE323 Developing a Multi-Indication Wider Societal Value Model to Estimate the Economic Impact of Semaglutide in Canada

    Dec 1, 2025, 00:00

  • EE224 Cost-Effectiveness and Budget Impact of Increasing Peritoneal Dialysis Utilization Among End-Stage Kidney Disease Patients in South Korea

    Dec 1, 2025, 00:00

  • CO155 Inter-Version Comparison of the Boston Carpal Tunnel Questionnaire: A Clinical Validation Study of the Decision Tree-Based Version

    Dec 1, 2025, 00:00

  • CO78 Dupilumab Improves Lung Function and Asthma Control While Reducing Systemic Corticosteroid Use in Patients With Allergic Bronchopulmonary Aspergillosis: The Phase 2 LIBERTY ABPA AIRED Study

    Dec 1, 2025, 00:00

  • EPH263 Trends in Hospitalizations and Amputations in Diabetic Foot Ulcers (DFUs) in Germany 2019 to 2024

    Dec 1, 2025, 00:00

  • EPH66 Durable Medical Equipment and Ancillary Service Use in Rett Syndrome Management: A Global Comprehensive Review of Literature

    Dec 1, 2025, 00:00

  • EE203 Cost-Effectiveness Analysis of Health2Sync Application With Patient Management Program Compared to Traditional Care for Patients With Type 2 Diabetes Mellitus in Taiwan

    Dec 1, 2025, 00:00

  • PCR218 Social Media Listening Analysis of Cannabis Use in Patients With Inflammatory Bowel Disease

    Dec 1, 2025, 00:00

  • CO138 Impact of Individualized Neoantigen Therapies on Health, Productivity, and Health System Capacity Outcomes in Resected Melanoma in Belgium

    Dec 1, 2025, 00:00

  • RWD87 From Data to Decisions: Enhancing Real-World Data Quality: A Survey of Health Data Producers in France

    Dec 1, 2025, 00:00

  • SA59 Laboratory Testing Patterns in Patients With Breast Cancer Treated With CDK4/6 Inhibitors: A Multi-Country Electronic Health Record Study From the UK, Germany, and Japan

    Dec 1, 2025, 00:00

  • EPH189 Prevalence of Meningococcal Carriage by Serogroup in Adolescents and Young Adults: A Global Systematic Literature Review and Meta-Analysis

    Dec 1, 2025, 00:00

  • RWD52 Data-Driven Alerts to Support the Care of People Living With Epilepsy and Provide an Infrastructure for the Development of Real-World Evidence

    Dec 1, 2025, 00:00

  • MT22 Global Evaluation of Flexible Cysto-Nephroscope Usage Patterns in Percutaneous Nephrolithotomy Procedures

    Dec 1, 2025, 00:00

  • EE216 Cost-Effectiveness Analysis of Pharmacogenetic Testing to Guide Treatment for Children With Asthma

    Dec 1, 2025, 00:00

  • PCR74 Enhancing Patient Experience of Subcutaneous Administration in Oncology: Development of a Dedicated Patient-Reported Experience Measure (PREM) Questionnaire Based on a Structured and Collaborative Approach

    Dec 1, 2025, 00:00

  • HSD101 Self-Reported Health Related Quality of Life (HRQoL) in Patients With Ischemic Heart Disease: A Randomized Controlled Trial on Digital Health Pharmacist Interventions

    Dec 1, 2025, 00:00

  • CO101 Estimating the Long-Term Impact of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Treatments on the Annual Decline of Percent-Predicted Forced Expiratory Volume in One Second (ppFEV1) Compared to Established Clin ...

    Dec 1, 2025, 00:00

  • RWD28 Characteristics of Patients Treated With Biologic Agents for Moderate-to-Severe Atopic Dermatitis in Poland

    Dec 1, 2025, 00:00

  • HTA191 Identifying Methods Used Within Early Value Assessments for NICE: Results of a Scoping Review

    Dec 1, 2025, 00:00

  • CO142 Impact of Tafamidis Use in Colombian Patients Diagnosed With ATTR-CM on Health-Related Quality of Life During One Year of Follow-up: Real-World Study in Colombia

    Dec 1, 2025, 00:00

  • CO26 Bayesian Dynamic Borrowing to Enhance Evidence for New Therapies

    Dec 1, 2025, 00:00

  • Medicare Drug Price Negotiation Under the Inflation Reduction Act: Ensuring the Continuity of Critical Real-World Pharmaceutical Studies

    Dec 1, 2025, 00:00

  • SA15 Balancing Rigor and Feasibility of Real-World Data Demands in Germany Within the EU HTA Context: How Fit for Purpose Is the Routine Practice Data Collection (Anwendungsbegleitende Datenerhebung, AbD)?

    Dec 1, 2025, 00:00

  • EE71 Baseline Risk Heterogeneity in Cost-Effectiveness Analysis of the Diabetes Prevention Program

    Dec 1, 2025, 00:00

  • HTA226 Long-Term HTA Trends in Patient Organization Submissions to the NCPE and Future Perspectives

    Dec 1, 2025, 00:00

  • P42 A Systematic Review of Economic Modeling Challenges and Proposed Solutions for Rare Disease Technologies: An HTAi RDIG Initiative

    Dec 1, 2025, 00:00

  • MSR72 Development of an AI-Powered Tool to Accelerate and Enhance Systematic Literature Reviews for Evidence-Based Decision Making in Clinical Research

    Dec 1, 2025, 00:00

  • CO185 Preliminary Real-World Comparative Analysis of Trastuzumab Deruxtecan vs. Trastuzumab Emtansine in Second-Line HER2-Positive Metastatic Breast Cancer

    Dec 1, 2025, 00:00

  • MSR214 Using Directed Acyclic Graphs in Matching-Adjusted Indirect Comparison and Simulated Treatment Comparison: Systematic Review and Methodological Insights

    Dec 1, 2025, 00:00

  • PCR55 Delayed Access to Diabetes Technology in Children With Migration Background: A Cross-Sectional Study on Treatment Equity in Austria

    Dec 1, 2025, 00:00

  • HTA337 Too Advanced for STA, Too Common for HST? Navigating NICE Appraisals of Gene Therapies

    Dec 1, 2025, 00:00

  • MSR222 What Prompt Engineering Missed and How Context Engineering Fixes It

    Dec 1, 2025, 00:00

  • HTA41 Are Women’s Health Strategies Driving Change? A Review of NICE and SMC HTAs

    Dec 1, 2025, 00:00

  • EE546 Improved Outcomes and Cost Savings With the New-Generation Balloon-Expandable Covered Stent in Aortoiliac Occlusive Disease: Preliminary Results Overview From an Italian Perspective

    Dec 1, 2025, 00:00

  • HTA99 Costs and Their Impacts That Should Be Included in Health Technology Assessment of Remote Palliative Care

    Dec 1, 2025, 00:00

  • MSR91 Evaluating Bayesian Borrowing Methods for Treatment Effect Extrapolation: A Simulation-Based Study

    Dec 1, 2025, 00:00

  • EE231 Cost-Effectiveness Model of Ranolazine for Treating Chronic Stable Angina Patients From Kingdom of Saudi Arabia Perspective

    Dec 1, 2025, 00:00

  • RWD27 Challenges and Opportunities in Using Real-World Data for Healthcare in the Middle East and North Africa Region: A Systematic Scoping Review

    Dec 1, 2025, 00:00

  • EE166 Cost Effectiveness and Budget Impact Analysis of Benralizumab for Treating Severe Uncontrolled Eosinophilic Asthma in Egypt

    Dec 1, 2025, 00:00

  • EPH249 The Incidence, Mortality, and Survival of Nonmetastatic Colorectal Cancer (CRC) per TNM Stages in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis

    Dec 1, 2025, 00:00

  • CO164 Mind the Gap: A Need for Guidance on Modeling Disease Activity Outcomes in Economic Models

    Dec 1, 2025, 00:00

  • CO53 Comparative Effectiveness of Alectinib vs. Crizotinib as First-Line Therapy in ALK-Positive Non-Small Cell Lung Cancer: A Real-World Quasi-Experimental Study

    Dec 1, 2025, 00:00

  • Inequality Aversion in Health: Eliciting Aversion to Univariate Health Inequalities Across Different Health Distributions

    Dec 1, 2025, 00:00

  • HTA11 A NICE Idea? Assessing the Impact of the Severity Modifier in Oncology and Nononcology Single Technology Appraisals

    Dec 1, 2025, 00:00

  • EPH177 Perspectives on Progress: A Qualitative Study of HIV Prevention Efforts in the Czech Republic

    Dec 1, 2025, 00:00

  • RWD96 Health-Related Quality of Life in Adults With Dry Eye Disease in Fran Insights From a Multicenter Observational Study

    Dec 1, 2025, 00:00

  • CO183 Potential Benefits of Universal Influenza Vaccination on Health Outcomes and Costs in Mexico

    Dec 1, 2025, 00:00

  • P9 Exploring Variability in EQ VAS Scores: A Systematic Review and Meta-Regression of Population Health Studies

    Dec 1, 2025, 00:00

  • EPH234 The Estimation of the Prevalent Presymptomatic Type 1 Diabetes Population in Germany Using a Patient Funnel Model

    Dec 1, 2025, 00:00

  • HSD31 Definitive Staging and Perioperative Treatment for Resectable Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC): A UK Perspective

    Dec 1, 2025, 00:00

  • SA57 Internal Validation of Type 2 Diabetes and Cardiovascular Events Incidences in the Core Obesity and Diabetes Model

    Dec 1, 2025, 00:00

  • MT2 Adoption of AI Clinical Decision Support Systems in Primary Care: An Evaluation of Physician Acceptance

    Dec 1, 2025, 00:00

  • EE538 Impact of Nirsevimab on the Health Burden and Costs of Respiratory Syncytial Virus (RSV) in the Infant Population From the Healthcare System in Argentina

    Dec 1, 2025, 00:00

  • EE142 Comparing the Economic Burden in Patients With vs. Without Ehlers-Danlos Syndrome (EDS) Using a Large US Electronic Health Records Database

    Dec 1, 2025, 00:00

  • HSD95 Real-World Hospital Stays Description and Cost Analysis of Immune Checkpoint Inhibitors (ICIs) Using National PMSI Data in France

    Dec 1, 2025, 00:00

  • P28 Survival Time-Adjusted Indirect Comparisons: A New Methodology for Comparing Between Phases of Treatment in Early Cancer

    Dec 1, 2025, 00:00

  • EE297 Cost-Utility Analysis of Adding Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors or Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists to Standard Therapy in Thai Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Diseas ...

    Dec 1, 2025, 00:00

  • HTA156 From Pilot to Platform: Expanding Generative AI Coauthoring Across Global Value Dossier (GVD) Sections With Proven Quality and Validation

    Dec 1, 2025, 00:00

  • EE107 Budget Impact of Including Cannabis-Based Products in Brazil’s Public Health System: A Scenario Analysis

    Dec 1, 2025, 00:00

  • EPH58 Detection of a Potential Pericarditis Safety Signal Associated With Azithromycin: Evidence From FAERS Disproportionality Analysis

    Dec 1, 2025, 00:00

  • EE39 Addressing the Impact of Alzheimer’s Disease on Care Capacity in the Netherlands: Implications for Health Technology Assessment

    Dec 1, 2025, 00:00

  • HTA15 A Review of Utility Data Used in Health Technology Assessments From the Perspective of a Health Technology Assessment Body

    Dec 1, 2025, 00:00

  • PCR148 Listening to the Voice of the Patient: Insights From a Survey on the Burden of Recurrent Respiratory Papillomatosis in the United States

    Dec 1, 2025, 00:00

  • CO216 Safety and Efficacy of Antibody Drug Conjugate (ADCs) in Pretreated Locally Advanced/Metastatic (LA/m) Triple-Negative Breast Cancer (TNBC): Systematic Literature Review (SLR)

    Dec 1, 2025, 00:00

  • SA55 Innovative Approaches to Real-World Evidence Generation: The Role of Italian Community Pharmacies

    Dec 1, 2025, 00:00

  • EE20 A Method to Estimate Causally Related Cost Savings of a Preventive Intervention: An Analysis Using the Wellness-Star∗ Database

    Dec 1, 2025, 00:00

  • EE376 Economic Evaluation Of Cefiderocol for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii in Italy Using Real-World Evidence

    Dec 1, 2025, 00:00

  • EPH67 Economic and Epidemiological Burden of Type 1 Diabetes In France

    Dec 1, 2025, 00:00

  • EE17 A Cost-Utility Analysis of Sparsentan for the Treatment of Immunoglobulin A Nephropathy in the UK

    Dec 1, 2025, 00:00

  • PCR124 Identification of Clusters of Patients With Similar Baseline Characteristics in the FOCAL-MS2 Study Evaluating Patient’s Autonomy

    Dec 1, 2025, 00:00

  • EE14 A Cost-Minimization and Budget Impact Analysis of NT-proBNP Screening for Systematic Sclerosis-Related Pulmonary Arterial Hypertension in an Australian Healthcare Setting

    Dec 1, 2025, 00:00

  • OP25 Understanding the Needs and Aspirations of Emerging HEOR Talent: Results From the ISPOR New Professional and Student Survey

    Dec 1, 2025, 00:00

  • EE543 Impact of Temporarily Implanted Nitinol Device in the Treatment of Urinary Symptoms in Patients With Benign Prostatic Obstruction in Spain

    Dec 1, 2025, 00:00

  • EE218 Cost-Effectiveness Analysis of RefluxStop for Treatment of Chronic Gastro-esophageal Reflux Disease: A US Medicare Perspective

    Dec 1, 2025, 00:00

  • P17 Implementation of Patient Experience Data in Clinical Trial Design: A Literature Review and Semi-Structured Interviews

    Dec 1, 2025, 00:00

  • MSR80 Economic Valuation of Premature COVID-19 Mortality in Kuwait: A Comparative Analysis of Three Methodological Approaches

    Dec 1, 2025, 00:00

  • EE15 A Cost-Minimization and Budget Impact Analysis of NT-proBNP Screening Test for Risk Assessment and Monitoring of Pulmonary Arterial Hypertension (PAH) Patients in Australian Healthcare Setting

    Dec 1, 2025, 00:00

  • PCR38 Care Partner Burden and Experiences With Schizophrenia: A National Canadian Survey

    Dec 1, 2025, 00:00

  • HTA65 Caregiver Quality of Life in Orphan Drug Health Technology Assessment Submissions in Europe: A Comparative Analysis

    Dec 1, 2025, 00:00

  • HPR188 Solving the PICO Puzzle: Perspectives on Outcome Measures for Oncology Medicines in Assessments of the European Medicines Agency and Health Technology Assessment Organizations in Europe

    Dec 1, 2025, 00:00

  • EE102 Budget Impact and Clinical Outcomes of Energy- and Nutrient-Dense Formulas in Pediatric Disease-Related Malnutrition: A Middle Eastern Analysis

    Dec 1, 2025, 00:00

  • HSD2 A Comprehensive Approach Including Mailed FITs and Nurse Navigation for Colorectal Cancer Screening

    Dec 1, 2025, 00:00

  • EPH224 Survival Trends in Multiple Myeloma by Treatment Era in the United States

    Dec 1, 2025, 00:00

  • HPR43 Characterizing Medicines Reimbursed Under Managed Access Protocols in Ireland (2006-2025)

    Dec 1, 2025, 00:00

  • P27 Predicting Treatment Effect on the Loss of Ability to Rise From Floor in Duchenne Muscular Dystrophy Using Individual Trajectories: An Application of Joint Modeling in FOR-DMD

    Dec 1, 2025, 00:00

  • HPR230 Unlocking Access: Overcoming Barriers and Harnessing Enablers for Innovative Payment Models for Pharmaceutical Innovation in Europe

    Dec 1, 2025, 00:00

  • MSR24 AI-Driven Simulation of FDA DCOA Review to Inform Evidence Planning and Regulatory Strategy

    Dec 1, 2025, 00:00

  • CO250 Therapeutic Benefit of Radiotherapy in Uterine Serous Carcinoma (USC): A Real-World Study

    Dec 1, 2025, 00:00

  • CO223 Symptom Relief With Vonoprazan Treatment in Gastroesophageal Reflux Disease Patients With Diabetes in China: Post Hoc Analysis of the VIEW Study

    Dec 1, 2025, 00:00

  • SA29 Design, Implementation, Data Analysis on the Time-Motions Studies: A Targeted Literature Review

    Dec 1, 2025, 00:00

  • HSD96 Real-World Study on Length of Hospital Stay and Economic Burden of AECOPD Inpatients in a Traditional Chinese Medicine Hospital in China

    Dec 1, 2025, 00:00

  • HTA312 The 90-Day Ambition: Historical Analysis of 200 NICE Appraisals to Assess Proportion-Achieving Final Guidance Within 90 Days of MHRA Approval

    Dec 1, 2025, 00:00

  • HTA267 Patient-Centered Hearing Technology Assessment: Integrating ICF Into Multicriteria Decision Making

    Dec 1, 2025, 00:00

  • HTA138 Evidence Strategy Starts Early: Integrating HTA Needs Through PICO Simulation in Metastatic Castration-Resistant Prostate Cancer

    Dec 1, 2025, 00:00

  • EE229 Cost-Effectiveness Evaluation of Combined Cervical Cancer Screening With CINtec PLUS in the Czech Republic

    Dec 1, 2025, 00:00

  • EPH33 Burden of Bloodstream Infections in the United States: Incidence and Healthcare Resource Utilization 2022-2024

    Dec 1, 2025, 00:00

  • HPR193 The Alignment Between Technology Incorporations and Actual Health Needs

    Dec 1, 2025, 00:00

  • MT37 Robotic Surgery: A Budget Analysis in the Italian Healthcare Setting

    Dec 1, 2025, 00:00

  • EE195 Cost-Effectiveness Analysis of CYP2C19 Genotype-Guided Antiplatelet Therapy for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention in the Netherlands

    Dec 1, 2025, 00:00

  • RWD172 Sex Differences in Characteristics and Treatment Patterns of Patients With Sleep Disorders in South Korea

    Dec 1, 2025, 00:00

  • EE452 Exit Strategies in Patients With Stable MS: Cost-Effectiveness of Extended Interval Dosing of Ocrelizumab and Natalizumab vs. De-escalating to Cladribine

    Dec 1, 2025, 00:00

  • EE366 Economic Burden of Systemic Lupus Erythematosus (SLE) Among Women in the USA: A Systematic Review

    Dec 1, 2025, 00:00

  • MSR207 Turning the Tables: AI Halves Table Extraction Time in HEOR Systematic Reviews

    Dec 1, 2025, 00:00

  • EE177 Cost of Adverse Events With the Bruton Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib in the First-Line Treatment of Chronic Lymphocytic Leukemia in Brazil

    Dec 1, 2025, 00:00

  • CO173 OncoLlama: Quantifying Cancer Inequalities at Population Scale Using Large Language Models for Clinical Text Abstraction

    Dec 1, 2025, 00:00

  • EPH106 Exploring the Broader Value of Adult Respiratory Vaccination Programs in Gree A Public Health Perspective

    Dec 1, 2025, 00:00

  • EE438 Evaluating the Cost-Effectiveness of Nasal Adrenaline Spray vs. Adrenaline Autoinjector for Treatment of Anaphylaxis: A Cost-Utility Modeling Approach

    Dec 1, 2025, 00:00

  • HSD38 Economic Burden and Healthcare Resource Utilization of Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Germany: A Claims Data Analysis

    Dec 1, 2025, 00:00

  • HTA136 Evaluating the Value Elements Considered in Health Technology Assessments of Paroxysmal Nocturnal Hemoglobinuria Treatments: A Targeted Review

    Dec 1, 2025, 00:00

  • MSR73 Development of Cardiovascular Risk Equations: Integrating Clinical Expertise With Data From the SELECT Trial

    Dec 1, 2025, 00:00

  • HTA66 CAR-T Therapy in Asia-Pacific: Is It Reimbursed in Your Country?

    Dec 1, 2025, 00:00

  • PT10 An Analysis of Possible Reference Countries for a US Most-Favored Nation Policy and the Associated Impact on the Global Pharmaceutical Industry

    Dec 1, 2025, 00:00

  • PT41 Health Economic Evaluations of Prevention and Management Strategies for Cholangiocarcinoma: A Systematic Review

    Dec 1, 2025, 00:00

  • SA52 Impact of Different Thresholds of Increasing or Decreasing Body Mass Index on Noncommunicable Diseases Through a Discrete Event Simulation Model

    Dec 1, 2025, 00:00

  • EPH240 The Health Impact of Pembrolizumab Plus Chemotherapy in the First-Line Treatment for Metastatic Triple-Negative Breast Cancer (TNBC) in Türkiye

    Dec 1, 2025, 00:00

  • PCR160 Mental Health Benefits of Exercise Variation: Evidence From the 2024 5EU National Health and Wellness Survey

    Dec 1, 2025, 00:00

  • HTA116 The Challenges of Evaluating Individualized Therapies in Health Technology Assessment: A Thematic Review

    Dec 1, 2025, 00:00

  • EPH261 Trends in Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Prescribing in England: A Data Analysis Using NHS Prescription Episodes Statistics (PES)

    Dec 1, 2025, 00:00

  • EPH113 Fostamatinib-Induced Hepatomegaly: A Novel Signal Identified Through US Food and Drug Administration Adverse Event Reporting System (FAERS) Database

    Dec 1, 2025, 00:00

  • EE265 Cost-Effectiveness of Pegcetacoplan for the Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients With Treatment Failure After C5 Inhibitor Therapy: An Analysis From the Brazilian Public Healthcare System Perspective

    Dec 1, 2025, 00:00

  • HPR199 The Enduring Economic Burden of COVID-19 and the Value of Vaccination Strategies in High-Income Countries

    Dec 1, 2025, 00:00

  • EE570 Malnutrition-Related Healthcare Costs in Hospitalized IBD Patients: A Nationwide Real-World Data Analysis in Italy

    Dec 1, 2025, 00:00

  • HTA147 Focus on Two Years of Economic Opinions on Solid Cancers (2023-2024): What Are the Specific Features vs. 2021-2022?

    Dec 1, 2025, 00:00

  • HTA330 The Role of Health-Related Quality of Life in German HTA Decisions: An Analysis of G-BA Assessments From 2020-2024

    Dec 1, 2025, 00:00

  • EE353 Economic Burden and Health-Related Quality of Life Associated With Schizophrenia in Saudi Arabia

    Dec 1, 2025, 00:00

  • P64 Patient Engagement in Economic Evaluations of Cancer Care: Mapping the Landscape and Advancing Practice

    Dec 1, 2025, 00:00

  • EE498 Healthcare Burden Among Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Targeted Literature Review

    Dec 1, 2025, 00:00

  • HPR217 Three Systems, One Market? A Comparative Analysis of Medical Device Reimbursement in Germany, Austria, and Switzerland

    Dec 1, 2025, 00:00

  • HSD73 Medication Patterns of Traditional Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Real-World Data Analysis

    Dec 1, 2025, 00:00

  • MT26 HTA Requirements for Medical Technologies in Germany

    Dec 1, 2025, 00:00

  • HTA357 Vignette-Based Economic Models in UK HTA Submissions: Valuable Tool or Just NICE in Theory?

    Dec 1, 2025, 00:00

  • EE209 Cost-Effectiveness Analysis of Isavuconazole vs. Liposomal Amphotericin B for the Treatment of Invasive Mucormycosis in Morocco

    Dec 1, 2025, 00:00

  • PCR94 Exploring the Promise of Generative AI for Coding and Analyzing Qualitative Patient Data: Results From a Pilot Study in Non-Hodgkin’s Lymphoma

    Dec 1, 2025, 00:00

  • SA77 Premium Relief Through Prevention: Actuarial Valuation of Herpes Zoster Vaccination

    Dec 1, 2025, 00:00

  • MSR69 Developing an HER-Based Multifeature Machine Learning Model to Identify Lung Cancer Subtype

    Dec 1, 2025, 00:00

  • CO215 Roflumilast Foam 0.3% in Patients With Psoriasis of the Scalp and Body: Improvements in Patient-Reported Outcomes and Quality of Life

    Dec 1, 2025, 00:00

  • HSD90 Potential Operational Efficiencies of a Combination Influenza and COVID-19 Vaccine in US Pharmacies

    Dec 1, 2025, 00:00

  • CO129 Healthcare Resource Utilization and Disease Progression in Patients With Primary Hyperoxaluria: A Retrospective Cohort Study

    Dec 1, 2025, 00:00

  • CO84 Effective Use of Reconstructed Survival Data for Individual-Level Correlation Assessment in Oncology: A Case Study in Metastatic-Hormone Sensitive Prostate Cancer (mHSPC)

    Dec 1, 2025, 00:00

  • MSR6 A Multistate Framework for Analyzing Outcomes in Diffuse Large B-cell Lymphoma With Autologous Hematopoietic Stem Cell Transplant

    Dec 1, 2025, 00:00

  • PCR199 Qualitative Assessment of Women’s Experiences of Sleep Disturbances Associated With Menopause to Evaluate Content Validity of Patient-Reported Outcomes

    Dec 1, 2025, 00:00

  • EE87 Budget Impact Analysis of Hyaluronic Acid Viscosupplementation for Knee Osteoarthritis in Colombia

    Dec 1, 2025, 00:00

  • MSR125 Human Alignment on Evaluating LLMs for Literature Review Extraction

    Dec 1, 2025, 00:00

  • CO162 Matching-Adjusted Indirect Comparison Between Garadacimab and Donidalorsen for Long-Term Prophylaxis in Hereditary Angioedema

    Dec 1, 2025, 00:00

  • EE598 Optimal Utilization of Robotic-Assisted Surgery in the NHS: A System-Level Economic Evaluation Model

    Dec 1, 2025, 00:00

  • MSR157 Optimized Piecewise Exponential Modeling Using Dynamic Programming: An Illustration From Treatment-Naïve Advanced Melanoma

    Dec 1, 2025, 00:00

  • RWD123 Medication Use in Indolent Systemic Mastocytosis (ISM) in Germany Prior to Avapritinib EMA Approval

    Dec 1, 2025, 00:00

  • EE595 Obstructive Sleep Apnea (OSA) Phenotypes and the Personalized Impact of Positive Airway Pressure (PAP) Therapy on Healthcare Resource Use

    Dec 1, 2025, 00:00

  • P7 Life-Cycle Economic Modeling to Determine the Evolving Value of a Tumor-Agnostic Precision Oncology Therapy With Conditional Marketing Authorization

    Dec 1, 2025, 00:00

  • PCR117 Health-Related Quality of Life in Patients Living With Osteosarcoma in Europe: A Systematic Review

    Dec 1, 2025, 00:00

  • EE489 Health Economic Assessment of Cefepime-Enmetazobactam for Treating Complicated Urinary Tract Infections: A German Payer Perspective

    Dec 1, 2025, 00:00

  • EE315 Cost Utility of Subcutaneous Methotrexate As a Second-Line Treatment for Moderate to Severe Rheumatoid Arthritis in the UK

    Dec 1, 2025, 00:00

  • EE541 Impact of Real-World Effectiveness vs. Previous Assumptions on Estimates of Economic and Clinical Benefit of 20-Valent Pneumococcal Conjugate Vaccine in Adults Across Countries

    Dec 1, 2025, 00:00

  • EE660 Societal and Economic Impact of NOAC Therapy for Deep Vein Thrombosis and Pulmonary Embolism in Bulgaria

    Dec 1, 2025, 00:00

  • CO36 Cardioprotective Medication Use Among Diabetic Patients With ASCVD in Qatar's Primary Care Setting

    Dec 1, 2025, 00:00

  • MSR121 How Does the Source of Transition Probabilities Influence Natural History Simulation and Economic Evaluation in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?

    Dec 1, 2025, 00:00

  • EE30 A Review of Health Economic Modeling Challenges for Opioid Use Disorder Treatment in Prison Settings

    Dec 1, 2025, 00:00

  • HTA348 US PIE and AMCP Dossiers: Payer Preferences Best Practice and a Comparison With Global Evidence Dossiers

    Dec 1, 2025, 00:00

  • EPH88 Estimating the Future Burden of Unvaccinated Girls Against Human Papilloma Virus (HPV) in Europe: A Modeling Study

    Dec 1, 2025, 00:00

  • P31 Comparative Performance of the EQ-5D-5L and PROMIS-10 in the Elderly: Data From the EQ-DAPHNIE Project in Five Countries

    Dec 1, 2025, 00:00

  • EE278 Cost-Effectiveness of Supportive Exercise Interventions for Colorectal Cancer Surgery: An Economic Evaluation of the PREPARE-ABC Multicenter, Randomized, Controlled Trial

    Dec 1, 2025, 00:00

  • PCR250 Treatment Preferences in Adults With Chronic Spontaneous Urticaria Symptomatic on H1-Antihistamines in China: Insights From CHOICE-CSU 2 Study

    Dec 1, 2025, 00:00

  • MSR130 Improving Indirect Treatment Comparisons via an Alternative MAIC Patient Weighting Method

    Dec 1, 2025, 00:00

  • PT35 Cost-Effectiveness Analysis of Ribociclib Plus Endocrine Therapy for the Treatment of HR/HER2 Early Breast Cancer in Greece

    Dec 1, 2025, 00:00

  • Author Reply

    Dec 1, 2025, 00:00

  • EE698 The Economic Burden of Acromegaly Disease in the Kingdom of Saudi Arabia

    Dec 1, 2025, 00:00

  • EPH259 Trends and Characteristics of Thrombectomy Use in Acute Ischemic Stroke in Germany (2019-2024): Insights From National Claims Data

    Dec 1, 2025, 00:00

  • HSD22 Characteristics and Treatment of Prevalent Heart Failure in the US: A Cross-Sectional Analysis of Annual Trends From 2014-2023

    Dec 1, 2025, 00:00

  • CO241 The Impact of Generalized Anxiety Disorder on Comorbid Conditions: A Systematic Review

    Dec 1, 2025, 00:00

  • EE629 Quantifying the Impact of Inconsistencies in Economic Modeling Assumptions: A Case Study in Metastatic Colorectal Cancer

    Dec 1, 2025, 00:00

  • MSR31 Applying Simulation-Guided Trial Design Principles to Prospectively Plan Target Trial Emulation of a Cluster Randomized Trial for Vaccine Coverage

    Dec 1, 2025, 00:00

  • EPH256 The Use of Multiple Sleep Medications Is Highly Prevalent

    Dec 1, 2025, 00:00

  • EE759 Workforce and Environmental Impact of Home-Based vs. Hospital-Based Administration of Second-Line MS Therapies in the Netherlands: A Comparative Analysis of Personnel Time and Carbon Footprint

    Dec 1, 2025, 00:00

  • RWD110 Integrating Prospective and Retrospective Real-World Data to Construct External Comparator Arms: Novel Methods and Design Considerations

    Dec 1, 2025, 00:00

  • HSD114 Treatment Characteristics of Breast Cancer Patients per HER2/HR Status in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis

    Dec 1, 2025, 00:00

  • HTA8 A Long and Winding Road: An Evaluation of NICE HST Appraisals Taking Longer Than Two Years for Guidance Publication

    Dec 1, 2025, 00:00

  • EE191 Cost-Consequence Analysis of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Treatment vs. Large-Volume Paracentesis (LVP) in the Management of Refractory Ascites: Preliminary Results Overview From an Italian Healthcare Perspecti ...

    Dec 1, 2025, 00:00

  • HTA342 Trends and Tensions in NICE Severity Modifiers: Analyzing the Acceptance and Critique of Manufacturer Severity Modifier Proposals in Recent Appraisals

    Dec 1, 2025, 00:00

  • RWD128 Obesity and MASH in the UK

    Dec 1, 2025, 00:00

  • HTA30 An Irish Retrospective Analysis of Oncology Reimbursement Applications Considered by HSE Drugs Group 2022-2024

    Dec 1, 2025, 00:00

  • EPH51 Comparative Prevalence of Suicidal Ideation and Self-Harm History: Rexulti vs. Other Oral Atypical Antipsychotics

    Dec 1, 2025, 00:00

  • MSR151 Modeling the Future Clinical and Environmental Burden of Chronic Kidney Disease in Ghana and Uganda Between 2025 and 2030

    Dec 1, 2025, 00:00

  • HTA246 Navigating Large Evidence Bases for MTEP Submissions

    Dec 1, 2025, 00:00

  • HSD118 Trends in Receipt of Preventive Healthcare Services from 2020-2024: US Electronic Health Records (EHR) Database Analysis of 118 Million Patients

    Dec 1, 2025, 00:00

  • EE198 Cost-Effectiveness Analysis of Fixed-Dose Combination Rosuvastatin and Ezetimibe vs. Simvastatin Plus Ezetimibe for the Treatment of Hypercholesterolemia in Patients at High Risk and Very High Risk of Cardiovascular Disease in Algeria ...

    Dec 1, 2025, 00:00

  • CO253 Transfusion Healthcare Resource Utilization and Associated Impact of Quality of Life Among Patients With Myelofibrosis and Anemia: A Multinational Real-World Survey

    Dec 1, 2025, 00:00

  • MSR122 How Far Have We Come With EQ-5D-5L Value Sets? An Updated Systematic Literature Review of 55 Valuation Studies

    Dec 1, 2025, 00:00

  • SA23 Correspondence Between Patients' and Neurologists' Satisfaction With Treatment in Patients With CIDP: Results From a Real-World International Survey

    Dec 1, 2025, 00:00

  • HTA217 Landscape Analysis of Initiatives to Improve Access to Orphan Drugs Led by Industry Patient and Academic Stakeholders

    Dec 1, 2025, 00:00

  • EPH5 A Real-World Study on Hospital and Economic Burden of Dengue Fever in French Overseas Territories

    Dec 1, 2025, 00:00

  • EPH4 A Person-Centered Approach: Exploring Social Support Network and Mental Health Among Shoebox House Residents in Hong Kong

    Dec 1, 2025, 00:00

  • EE93 Budget Impact Analysis of Ondansetron Oral Dissolving Film vs. Oral Solution in the Chemotherapy-Induced Nausea and Vomiting for Egyptian Pediatric Patients

    Dec 1, 2025, 00:00

  • EE313 Cost-Utility of Intramuscular Testosterone for Men and Male Adolescents With Organic Hypogonadotropic Hypogonadism in Brazil

    Dec 1, 2025, 00:00

  • PCR198 Psychometric Validation Of The North Star Assessment For Limb-Girdle Type Muscular Dystrophies (NSAD) In Limb-Girdle Muscular Dystrophy Sarcoglycanopathies (LGMD 2C/2D/2E) Using Baseline JOURNEY Data

    Dec 1, 2025, 00:00

  • SA75 Performance of Large Language Model Clinical Data Extraction by Data Domain: A Rapid Systematic Review

    Dec 1, 2025, 00:00

  • CO196 Qualitative Literature Review Exploring the Patient Experience of Shortness of Breath in COPD and Asthma

    Dec 1, 2025, 00:00

  • HPR140 MCDA Tool Adoption in Egypt: Room for Sustainability and Accessibility

    Dec 1, 2025, 00:00

  • RWD163 Real-World Study of Breast Cancer Epidemiology and Treatment Patterns: A Pilot Study to Assess EHR-Derived Data in the United Kingdom

    Dec 1, 2025, 00:00

  • EPH251 The PHEBUS Study: A Retrospective Analysis of the Burden of Pneumococcal Infections in the Pediatric Population Using the French Hospital Discharge Database (PMSI)

    Dec 1, 2025, 00:00

  • SA73 Occurrence of Exacerbations and Mortality in High-Risk Chronic Obstructive Pulmonary Disease Patients While on Treatment With Dual or Triple Inhaled Therapy: Results From the SIRIUS Observational Study in the US

    Dec 1, 2025, 00:00

  • CO27 Bayesian Network Meta-Analysis of Weight Loss Efficacy for GLP-1 Receptor Agonists and Tirzepatide

    Dec 1, 2025, 00:00

  • EE261 Cost-Effectiveness of Mixed-Approach Maternal RSVpreF/Infant Nirsevimab Immunization vs. Nirsevimab Alone for Prevention of Respiratory Syncytial Virus in Spain

    Dec 1, 2025, 00:00

  • OP18 Overview of Hospital Management of Patients Treated With Thoracic Endovascular Repair (TEVAR) and Revascularization of the Left Subclavian Artery in France Based on the PMSI

    Dec 1, 2025, 00:00

  • CO249 The Value of Persistence in Neovascular Age-Related Macular Degeneration

    Dec 1, 2025, 00:00

  • EE161 Cost-Effectiveness Analysis of Ga-PSMA-11 PET/CT Imaging Followed by Lu-PSMA-617 vs. Standard of Care in Metastatic Castrate-Resistant Prostate Cancer

    Dec 1, 2025, 00:00

  • EE672 Stop Ignoring Missing Patients the Hidden Impact of Ignoring Missing Data in Health State Utility Estimation

    Dec 1, 2025, 00:00

  • HTA318 The HTA Landscape of Orphan Products in the UK Between 2019 and 2024

    Dec 1, 2025, 00:00

  • PCR181 Patient Preferences in Gene Therapy Development for Arrhythmogenic Cardiomyopathy: The UR-HEART Qualitative Study

    Dec 1, 2025, 00:00

  • EE180 Cost of First-Line Treatment of Hepatocellular Carcinoma With the Immune Checkpoint Inhibitor-Based Regimens STRIDE and Atezolizumab Plus Bevacizumab in Brazil

    Dec 1, 2025, 00:00

  • SA56 Integrating Stakeholder Insights Into Thematic Analysis: Enhancing Efficiency and Supporting HEOR

    Dec 1, 2025, 00:00

  • EPH194 Productivity Costs Due to Respiratory Infections in Denmark: A Potential for Prophylaxis

    Dec 1, 2025, 00:00

  • HTA196 Implementation and Outcomes of Managed Entry Agreements Across the Nordic Region

    Dec 1, 2025, 00:00

  • SA47 Global Trade Shocks and Exchange Rate Effects on Pharmaceutical Reference Pricing: Implications of EU Stimulus for US MFN Policy

    Dec 1, 2025, 00:00

  • HPR146 Navigating the Influence of Traditional Chinese Medicine (TCM) on the Positioning of New Treatments in China: A Review of TCM Inclusion in Clinical Guidelines

    Dec 1, 2025, 00:00

  • PCR67 Effectiveness of Vonoprazan on Health-Related Quality of Life and Sleep Quality in Chinese Patients With Reflux Esophagitis: Post Hoc Analysis of the VIEW Study

    Dec 1, 2025, 00:00

  • MSR67 Defining Patient-Centered Outcomes in CAR-T-cell Therapy: Is There a Need for a Patient-Informed CAR-T PROM?

    Dec 1, 2025, 00:00

  • EE677 Systematic Literature Review of the Use of Generative AI in Health Economic Evaluation

    Dec 1, 2025, 00:00

  • EE422 Estimating Quality-Adjusted Life Expectancy by Ethnicity for Application in Distributional Cost-Effectiveness Analysis

    Dec 1, 2025, 00:00

  • CO56 Comparative Efficacy of Asciminib vs. Second-Generation TKIs in Newly Diagnosed PhCML Using Unanchored Matching-Adjusted Indirect Comparisons

    Dec 1, 2025, 00:00

  • EE58 Assessing the Budget Impact of Bimekizumab in the Management of Hidradenitis Suppurativa in France

    Dec 1, 2025, 00:00

  • MSR107 Facilitator-Led vs. Remote Components Within Structured Expert Elicitation of Survival Outcomes: A Targeted Review

    Dec 1, 2025, 00:00

  • PT29 From Code to Quality: Identifying Quality Assurance Steps for AI Integration in Qualitative Healthcare Research: A Comparative Study of ChatGPT, Atlas.ti, and Traditional Coding

    Dec 1, 2025, 00:00

  • HPR57 Distributional Cost-Effectiveness Analysis Across the Globe: How Feasible Is It Really?

    Dec 1, 2025, 00:00

  • HTA202 Insights and Implications an Analysis of the Studies Undertaken by HTAIn (Health Technology Assessment in India)

    Dec 1, 2025, 00:00

  • EPH198 Public Health Impact of 25 Years of Pneumococcal Conjugate Vaccination in Children 5 Years Old: A Modeling Analysis

    Dec 1, 2025, 00:00

  • MT7 Assessing the Economic Impact of a Robotic-Assisted Solution vs. a Manual Approach in Total Knee Arthroplasty in the UK

    Dec 1, 2025, 00:00

  • HPR104 From Policy to Practi Are Larger Member States Leading the Way for Joint Clinical Assessments?

    Dec 1, 2025, 00:00

  • EE7 A Conceptual Paper on Integrating a Pharmacometric Multistate Model With Cost-Effectiveness Analysis for Infectious Diseases Treatment Optimization

    Dec 1, 2025, 00:00

  • MT44 Unraveling the Challenges of Multiplex Cell Culture Technology Using the HTA Core Model

    Dec 1, 2025, 00:00

  • PCR150 Looking Back to Go Forward: Reintegrating Scientific Considerations Into eCOA Design and Implementation

    Dec 1, 2025, 00:00

  • PCR65 Diagnostic Odyssey of Patients With the Rare Immunodeficiency-Activated PI3 Kinase Delta Syndrome (APDS): Case Study With Expert Interviews and Patient Surveys

    Dec 1, 2025, 00:00

  • EE277 Cost-Effectiveness of Strategies to Prevent Respiratory Syncytial Virus Infections Among Infants in Ireland

    Dec 1, 2025, 00:00

  • Physician-Directed Reinvestment: A Novel Cost-Savings Framework for Hospital Systems That Leverages Frontline Physicians

    Dec 1, 2025, 00:00

  • MT46 Value of in Vitro Diagnostic IVD Tests in Health Society and Economy in Portugal

    Dec 1, 2025, 00:00

  • EE250 Cost-Effectiveness of Familial Hypercholesterolemia Cascade Testing in Thailand: A Comparative Analysis of Exome vs. Long-Read DNA Sequencing

    Dec 1, 2025, 00:00

  • EPH144 Incidence of Tick-Borne Encephalitis in Germany Comparison of Claims Data With Public Surveillance Data

    Dec 1, 2025, 00:00

  • HSD98 Real-World Treatment Patterns of US Patients With Platinum-Resistant Ovarian Cancer

    Dec 1, 2025, 00:00

  • EE169 Cost-Effectiveness of Nemolizumab in the Treatment of Patients With Moderate-to-Severe Prurigo Nodularis in Italy

    Dec 1, 2025, 00:00

  • MSR146 Metamodels SHAP Analysis: Unearthing Data Interactions

    Dec 1, 2025, 00:00

  • EE290 Costs Associated With the Treatment of Surgical Site Infections in Solid Organ Transplant Recipients: A Scoping Review

    Dec 1, 2025, 00:00

  • PCR196 Psychometric Performance of EQ-HWB for Japanese Populations

    Dec 1, 2025, 00:00

  • HSD6 Analysis of Pharmacists' Awareness on Post COVID-19 Conditions and Implementation in Postgraduate Education in Ukraine

    Dec 1, 2025, 00:00

  • ISPOR Europe 2025: Powering Value and Access Through Patient-Centered Collaboration

    Dec 1, 2025, 00:00

  • EE628 Quantifying the Fiscal Value of Prevention Programs for Depression

    Dec 1, 2025, 00:00

  • EE586 Modeled Number and Cost of Biparametric Magnetic Resonance Imaging (bpMRI) Examinations in a Nationwide Prostate Cancer Screening Program: Utilizing the Results of the Czech Prostapilot Study

    Dec 1, 2025, 00:00

  • P48 Empirical Comparison of Subjective Well-Being and Health-Related Quality of Life Measures in Australian Adolescents

    Dec 1, 2025, 00:00

  • EPH75 Epidemiological Characteristics and Economic Burden of IgA Nephropathy—a Retrospective Study Using Multicenter Electronic Medical Records Data in China

    Dec 1, 2025, 00:00

  • PCR222 Strengths and Limitations of AI-Assisted Abstract Screening to Identify Patient-Reported Outcome Instruments: A Comparison of Two AI-Assisted Platforms and Traditional Methods

    Dec 1, 2025, 00:00

  • PCR265 Wasfaty Improves Quality of Outpatient Pharmaceutical Service at a Tertiary Academic Hospital: A Descriptive Analysis

    Dec 1, 2025, 00:00

  • HTA314 The Development of the Multicriteria Decision Analysis in Specialized Burn Care: The Methodological Process

    Dec 1, 2025, 00:00

  • EE599 Optimization of the EVAR Pathway: An Integrated Organizational Model for Clinical Efficiency and Economic Sustainability

    Dec 1, 2025, 00:00
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »